Merck’s Covid Pill Is Authorized by F.D.A. for High-Risk Adultsnews2021-12-24T02:19:46+00:00December 24th, 2021|The New York Times|
F.D.A. Clears Pfizer’s Covid Pill for High-Risk Patients 12 and Oldernews2021-12-22T22:02:31+00:00December 22nd, 2021|The New York Times|
Pfizer’s Covid Pill Works Well, Company Confirms in Final Analysisnews2021-12-15T02:22:07+00:00December 15th, 2021|The New York Times|